Legal information Site Map Home Services Company news Research Events About us Careers Halla Koppel joins Bryan, Garnier & Co as Vice President in Investment Banking 11 OCTOBER 2021|IN COMPANY NEWS, NEW HIRES Halla Koppel Vice President | Reykjavík Investment Banking Bryan, Garnier & Co, a leading pan-European investment bank focusing on growth companies, is delighted to announce that Halla has been appointed as Vice President in Investment Banking. Halla joined Bryan, Garnier & Co in September as Vice President in investment banking with a specialisation in ESG products. Previously Halla worked at Goldman Sachs, as part of their cross-asset coverage for Nordic institutional clients. Halla has an MBA from the University of Oxford, holds a Certificate in Sustainable Finance from Cambridge University and a CFA level 4 in ESG investing. Halla also has a long career in media and entertainment behind her, has climbed four of the World´s highest Seven Summits and is a keen motorcyclist. With more than 60 private and public capital-raising and M&A transactions closed in 2020, Bryan, Garnier & Co benefits from longstanding leadership in the healthcare, technology, business services and environmental sectors in Europe. Over the past 36 months, Bryan, Garnier & Co has led more than 40 ECM transactions across nine countries, raising over EUR 2.5bn. Recent successes include the IPOs and/or follow-ons for HDF Energy (Euronext Paris), Mister SPEX (Deutsche Boerse), Carbios (Euronext Paris), Azelio (NASDAQ Stockholm), McPhy Energy (Euronext Paris), Linas Matkase (NASDAQ Stockholm), Heidelberg Pharma (Deutsche Börse), Swedish Stirling (NASDAQ Stockholm), Basilea (SIX) GenSight (Euronext Paris), and Valneva (NASDAQ / Euronext Paris). Additional recent transactions include the acquisition of DL Software by TA Associates, the sale of smartTrade to leading software private equity investor Hg Capital, the take-private of ITSM player Easyvista by Eurazeo, capital for circular economy player asgoodasnew, the sale of Specim to Konica Minolta and the sale of BlueBee to Illumina. Over the years, Bryan, Garnier & Co has distinguished itself by backing some of the most disruptive companies in the domain of alternative proteins (Prolupin), green hydrogen (McPhy Energy), cannabis (Canopy Growth), 3D printing (Materialise), blockchain and cryptocurrencies (Bitfury Group), and mRNA biotech (Moderna and BioNTech). About Bryan, Garnier & Co Bryan, Garnier & Co is a European, full-service growth-focused independent investment banking partnership founded in 1996. The firm provides equity research, sales and trading, private and public capital raising as well as M&A services to growth companies and their investors. It focuses on key growth sectors of the economy including Technology, Healthcare, Consumer and Business Services. Bryan, Garnier & Co is a fully registered broker dealer authorized and regulated by the FCA in the UK, the AMF in Europe and the FINRA in the U.S. Bryan, Garnier & Co is headquartered in London, with additional offices in Paris, Munich, Stockholm, Oslo, Reykjavik and New York. (www.bryangarnier.com) Menu Home All transactions Investment Banking Capital Markets Sectors Intelligence Other Events Our team Careers About us Contact us LEGAL LEGAL INFORMATION SITE MAP LATEST NEWS Behind the scene : the stake of private growth financing in the client lifecycle approach of Bryan, Garnier & Co Bryan, Garnier & Co, a leading pan-European investment bank focusing on growth companies, is delighted to announce that Alexandre has been appointed Senior Associate in the Business & Tech-enabled Services Team. Halla Koppel joins Bryan, Garnier & Co as Vice President in Investment Banking Caroline Brun joins Bryan, Garnier & Co as Vice President in the Business & Tech-enabled Services Team Jérôme Guyot joins Bryan, Garnier & Co as Managing Director – Equity Capital Markets We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsACCEPT